You have 9 free searches left this month | for more free features.

Myleran

Showing 76 - 95 of 95

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Lymphoma Trial (Busulfan, Caphosol, Glutamine)

Withdrawn
  • Lymphoma
  • (no location specified)
May 3, 2016

Leukemia Trial (Busulfan (Zhejiang Otsuka Pharmaceutical Co. Ltd), Cytarabine(Actavis Italy S.p.A), Fludarabine (Bayer))

Unknown status
  • Leukemia
  • Busulfan (Zhejiang Otsuka Pharmaceutical Co. Ltd)
  • +4 more
  • (no location specified)
May 24, 2016

Hematologic Tumors, Anemia, Aplastic, Hemoglobinuria, Paroxysmal Trial in Tucson (haploidentical allogeneic PBSC transp)

Completed
  • Hematologic Neoplasms
  • +3 more
  • haploidentical allogeneic PBSC transp
  • Tucson, Arizona
    Arizona Cancer Center/University Medical Center
Mar 1, 2016

Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in Detroit (drug, procedure, radiation)

No longer available
  • Leukemia
  • +5 more
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Feb 26, 2016

Leukemia, Chronic Myelogenous Leukemia Trial in Houston (Fludarabine, Busulfan, NK cell infusion:)

Completed
  • Leukemia
  • Chronic Myelogenous Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 4, 2016

Lymphoma Trial in Houston (Vorinostat, Gemcitabine, Busulfan)

Completed
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 17, 2015

Leukemia Trial in Houston (Busulfan, Cyclophosphamide, G-CSF)

Withdrawn
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 21, 2015

Hematological Disease Trial in Chicago (Melphalan, Fludarabine, Antithymocyte Globulin (ATG))

Terminated
  • Hematological Disease
  • Chicago, Illinois
    University of Chicago
Apr 10, 2015

Myelodysplastic Syndrome, Leukemia Trial in Houston (Thymoglobulin, Busulfan, Fludarabine)

Completed
  • Myelodysplastic Syndrome
  • Leukemia
  • Houston, Texas
    UT MD Anderson Cancer Center
May 6, 2015

MDS, Secondary Acute Myeloid Leukemia Trial in Worldwide (Reduced Intensity Conditioning, Myeloablative conditioning)

Terminated
  • Myelodysplastic Syndromes
  • Secondary Acute Myeloid Leukemia
  • Reduced Intensity Conditioning
  • Myeloablative conditioning
  • Düsseldorf, Germany
  • +13 more
Apr 2, 2015

Acute Leukemia, Chronic Leukemia, Lymphoproliferative Disease Trial in Sao Paulo (Analyze the pharmacokinetics of busulfan for

Unknown status
  • Acute Leukemia
  • +4 more
  • Analyze the pharmacokinetics of busulfan for transplantation
  • Sao Paulo, SP, Brazil
    Hospital Israelita Albert Einstein
Dec 2, 2014

Myeloma Trial (Carfilzomib, SAHA, Gemcitabine)

Withdrawn
  • Myeloma
  • (no location specified)
Jul 9, 2014

Leukemia, Lymphoma, MDS Trial in Cleveland (drug, radiation, procedure)

Completed
  • Leukemia
  • +3 more
  • Cleveland, Ohio
    Case Medical Center, University Hospitals Seidman Cancer Center,
Jun 19, 2013

Leukemia Trial in Canada, United States (drug, procedure, radiation)

Terminated
  • Leukemia
  • Birmingham, Alabama
  • +17 more
Oct 14, 2013

Leukemia, MDS Trial in Detroit (busulfan, cyclophosphamide, cyclosporine)

Completed
  • Leukemia
  • Myelodysplastic Syndromes
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Aug 6, 2012

Leukemia Trial in Houston (Busulfan, Fludarabine)

Completed
  • Leukemia
  • Houston, Texas
    U.T.M.D. Anderson Cancer Center
May 23, 2012

Leukemia Trial in Houston (Imatinib Mesylate, Fludarabine (Fludara), Busulfan)

Terminated
  • Leukemia
  • Imatinib Mesylate
  • +7 more
  • Houston, Texas
    UT MD Anderson Cancer Center
Apr 19, 2012

Hematologic Malignancies Trial in Houston (Busulfan, Fludarabine)

Completed
  • Hematologic Malignancies
  • Houston, Texas
    UT MD Anderson Cancer Center
Jan 24, 2012

Chronic Myelogenous Leukemia Trial in Houston (Busulfan, Cyclophosphamide, Imatinib Mesylate)

Completed
  • Chronic Myelogenous Leukemia
  • Houston, Texas
    UT MD Anderson Cancer Center
Oct 31, 2011

Acute Myeloid Leukemia Trial in Memphis (Busulfan, Cyclophosphamide, Mesna)

Completed
  • Acute Myeloid Leukemia
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Apr 25, 2008